1996•The Pediatric Infectious Disease JournalRequires access

MENINGITIS CAUSED BY NEISSERIA MENINGITIDIS C RELATIVELY RESISTANT TO PENICILLIN AND AMPICILLIN

Alicia Pisano, Gabriel Perez, María Hortal, Pablo Giordano

Open publisher page 0 citations

Abstract

To The Editors: Several communications from European countries have described isolates of Neisseria meningitidis with decreased susceptibility to penicillin and ampicillin,1, 2 and more recently North American publications3, 4 have reported strains of N. meningitidis relatively resistant to penicillin detected in the United States. Because information on resistance of N. meningitidis to penicillin is scarce in the Americas, we considered it relevant from the epidemiologic point of view5, 6 to alert physicians about its occurrence in Uruguay. The minimal inhibitory concentration (MIC) was determined for 84 invasive isolates by E-test® (AB Biodisk, Solna, Sweden) for penicillin, ampicillin, ceftriaxone, cefotaxime and rifampin. The tests were performed on Mueller-Hinton-enriched chocolate agar plates with incubation for 24 h in a candle jar at 35°C. All the results were read according to the break points established by the National Committee for Clinical Laboratory Standards for Neisseria gonorrhoea. For penicillin and ampicillin the break points were the following: susceptibility <0.06 μg/ml, relative resistance >0.06 to 1 μg/ml and resistance >1 μg/ml. Since 1989 we have been receiving invasive isolates of N. meningitidis at the Central Public Health Laboratory, Montevideo, Uruguay. In 1993 we detected for the first time eight isolates of N. meningitidis serogroup C with moderate resistance to penicillin and ampicillin (38%). Thereafter N. meningitidis C became the most frequent serogroup and the intermediate resistance increased to 91%, the increase persisting during 1995. None of the 84 isolates was a beta-lactamase producer or resistant to the tested cephalosporins and rifampin. Genetic studies are under way to trace the origin of these isolates. Alicia Pisano, M.Sc.; Gabriel Perez, M.Sc.; Maria Hortal, M.D.; Pablo Giordano, M.D. Central Public Health Laboratory (AP, GP, MH) Pasteur Hospital (PG) Montevideo, Uruguay

About this research paper

What this paper is about

To The Editors: Several communications from European countries have described isolates of Neisseria meningitidis with decreased susceptibility to penicillin and ampicillin,1, 2 and more recently North American publications3, 4 have reported strains of N. meningitidis relatively resistant to penicillin detected in the United States. Because information on resistance of N. meningitidis to penicillin is scarce in the Americas, we considered it relevant from the epidemiologic point of view5, 6 to alert physicians about its occurrence in Uruguay. The minimal inhibitory concentration (MIC) was determined for 84 invasive isolates by E-test® (AB Biodisk, Solna, Sweden) for penicillin, ampicillin, ceftriaxone, cefotaxime and rifampin. The tests were performed on Mueller-Hinton-enriched chocolate agar plates with incubation for 24 h in a candle jar at 35°C. All the results were read according to the break points established by the National Committee for Clinical Laboratory Standards for Neisseria gonorrhoea. For penicillin and ampicillin the break points were the following: susceptibility <0.06 μg/ml, relative resistance >0.06 to 1 μg/ml and resistance >1 μg/ml. Since 1989 we have been receiving invasive isolates of N. meningitidis at the Central Public Health Laboratory, Montevideo, Uruguay. In 1993 we detected for the first time eight isolates of N. meningitidis serogroup C with moderate resistance to penicillin and ampicillin (38%). Thereafter N. meningitidis C became the most frequent serogroup and the intermediate resistance increased to 91%, the increase persisting during 1995. None of the 84 isolates was a beta-lactamase producer or resistant to the tested cephalosporins and rifampin. Genetic studies are under way to trace the origin of these isolates. Alicia Pisano, M.Sc.; Gabriel Perez, M.Sc.; Maria Hortal, M.D.; Pablo Giordano, M.D. Central Public Health Laboratory (AP, GP, MH) Pasteur Hospital (PG) Montevideo, Uruguay

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

To The Editors: Several communications from European countries have described isolates of Neisseria meningitidis with decreased susceptibility to penicillin and ampicillin,1, 2 and more recently North American publications3, 4 have reported strains of N. meningitidis relatively resistant to penicillin detected in the United States. Because information on resistance of N. meningitidis to penicillin is scarce in the Americas, we considered it relevant from the epidemiologic point of view5, 6 to alert physicians about its occurrence in Uruguay. The minimal inhibitory concentration (MIC) was determined for 84 invasive isolates by E-test® (AB Biodisk, Solna, Sweden) for penicillin, ampicillin, ceftriaxone, cefotaxime and rifampin. The tests were performed on Mueller-Hinton-enriched chocolate agar plates with incubation for 24 h in a candle jar at 35°C. All the results were read according to the break points established by the National Committee for Clinical Laboratory Standards for Neisseria gonorrhoea. For penicillin and ampicillin the break points were the following: susceptibility <0.06 μg/ml, relative resistance >0.06 to 1 μg/ml and resistance >1 μg/ml. Since 1989 we have been receiving invasive isolates of N. meningitidis at the Central Public Health Laboratory, Montevideo, Uruguay. In 1993 we detected for the first time eight isolates of N. meningitidis serogroup C with moderate resistance to penicillin and ampicillin (38%). Thereafter N. meningitidis C became the most frequent serogroup and the intermediate resistance increased to 91%, the increase persisting during 1995. None of the 84 isolates was a beta-lactamase producer or resistant to the tested cephalosporins and rifampin. Genetic studies are under way to trace the origin of these isolates. Alicia Pisano, M.Sc.; Gabriel Perez, M.Sc.; Maria Hortal, M.D.; Pablo Giordano, M.D. Central Public Health Laboratory (AP, GP, MH) Pasteur Hospital (PG) Montevideo, Uruguay

Key concepts: Neisseria meningitidis, Ampicillin, Penicillin, Microbiology, Cefotaxime, Amp resistance, Ceftriaxone, Agar dilution

Related papers

Back to paper searchBrowse research topicsOriginal source